Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Stocks
US8902604094
Pharmaceuticals
| Market Cap | 208M 182M 168M 155M 294M 19.83B 299M 2.01B 787M 9.74B 780M 763M 33.72B | P/E 2026 * |
-1.27x | P/E 2027 * | -2.1x |
|---|---|---|---|---|---|
| Enterprise Value | 208M 182M 168M 155M 294M 19.83B 299M 2.01B 787M 9.74B 780M 763M 33.72B | EV / Sales 2026 * |
6.08x | EV / Sales 2027 * | 2.63x |
| Free-Float |
99.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| 1 day | +83.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 2007-11-15 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 2016-01-31 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 2025-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 2011-09-30 |
Margaret Bell
BRD | Director/Board Member | 66 | 2017-09-11 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.42% | -17.57% | - | - | 208M | |
| +0.09% | +0.25% | +54.65% | +169.19% | 1,085B | |
| -1.63% | -1.50% | +65.79% | +62.70% | 624B | |
| -1.12% | -4.27% | +31.10% | +84.44% | 442B | |
| +1.10% | -0.23% | +29.20% | +28.11% | 332B | |
| -1.18% | -8.74% | +24.15% | +29.59% | 277B | |
| +0.68% | -2.16% | +26.16% | +45.91% | 282B | |
| +0.28% | -1.79% | -29.52% | -39.53% | 217B | |
| -1.19% | -2.81% | +22.63% | +66.30% | 196B | |
| -0.72% | +2.72% | +19.07% | +81.19% | 167B | |
| Average | +8.11% | -1.86% | +27.03% | +58.65% | 402.44B | |
| Weighted average by Cap. | -0.18% | -1.06% | +38.40% | +85.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34.18M 29.91M 27.58M 25.52M 48.43M 3.26B 49.24M 330M 129M 1.6B 128M 126M 5.55B | 78.93M 69.05M 63.68M 58.92M 112M 7.53B 114M 763M 299M 3.7B 296M 290M 12.82B |
| Net income | -170M -149M -137M -127M -241M -16.22B -245M -1.64B -644M -7.97B -638M -624M -27.6B | -152M -133M -122M -113M -215M -14.49B -219M -1.47B -575M -7.12B -570M -558M -24.65B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
